Eli Lilly (LLY)
$745.69
14.36 (1.96%)
LLY Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.04M
Day's Range
$731.44 - $746.16
52-Week Range
$370.68 - $800.78
Dividend & Yield
$4.52 (0.61%)
LLY Stock Predictions, Articles, and Eli Lilly News
3 Stocks With the Potential to Knock Tesla Out of the Magnificent 7
These stocks are best positioned to usurp Tesla's position within Magnificent 7 stocks as it slumps further in February.
My Top 3 Stock Candidates to Replace Tesla in the Magnificent 7
The Magnificent 7 stocks are mostly doing well in 2024. It would still be a good bet if not for Elon Musk’s company.
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.
3 Pharma Stocks to Sell in February Before They Crash and Burn
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.
